Bibliome.ai browser hg19
Search
About
Stats
FAQ
KMT2C c.1315A>G ;(p.I439V)
Variant ID: 7-151949785-T-C
NM_170606.2(
KMT2C
):c.1315A>G;(p.I439V)
This variant was identified in 3 publications
View GRCh38 version.
Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP
Publications:
An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.
Frontiers In Immunology
Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y
Publication Date: 2022
Variant appearance in text: MLL3: 1315A>G
PubMed Link:
36505399
Variant Present in the following documents:
Table_2.xlsx, sheet 3
Table_2.xlsx, sheet 2
View BVdb publication page
The Mutational Landscape of Early-Onset Breast Cancer: A Next-Generation Sequencing Analysis.
Frontiers In Oncology
Andrikopoulou, Angeliki A; Chatzinikolaou, Spyridoula S; Kyriopoulos, Ilias I; Bletsa, Garyfalia G; Kaparelou, Maria M; Liontos, Michalis M; Dimopoulos, Meletios-Athanasios MA; Zagouri, Flora F
Publication Date: 2021
Variant appearance in text: KMT2C: 1315A>G; Ile439Val
PubMed Link:
35127508
Variant Present in the following documents:
Main text
fonc-11-797505.pdf
View BVdb publication page
TP53 mutations determined by targeted NGS in breast cancer: a case-control study.
Oncotarget
Andrikopoulou, Angeliki A; Terpos, Evangelos E; Chatzinikolaou, Spyridoula S; Apostolidou, Kleoniki K; Ntanasis-Stathopoulos, Ioannis I; Gavriatopoulou, Maria M; Dimopoulos, Meletios-Athanasios MA; Zagouri, Flora F
Publication Date: 2021-10-12
Variant appearance in text: KMT2C: Ile439Val
PubMed Link:
34676052
Variant Present in the following documents:
Main text
oncotarget-12-2206.pdf
View BVdb publication page